MedTrace Logo

UVB-Induced MVP Release in Human Skin

NCT05734235 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2023-02-24

No results posted yet for this study

Summary

This study is designed to assess if ultraviolet B radiation (UVB) found in sunlight causes the release of microvesicle particles in human skin, and if antioxidant vitamins can block their production.

Conditions

  • Ultraviolet B Radiation
  • Microvesicle Particles

Interventions

DIETARY_SUPPLEMENT

Vitamin C

Two Vitamin C tablets daily for 8 days.

DIETARY_SUPPLEMENT

Vitamin E

One Vitamin E tablet daily for 8 days.

Sponsors & Collaborators

  • Wright State University

    lead OTHER

Principal Investigators

  • Jeffrey B Travers, MD, PhD · Wright State University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-16
Primary Completion
2020-03-05
Completion
2022-10-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05734235 on ClinicalTrials.gov